KAS
REGN icon

Kestra Advisory Services’s Regeneron Pharmaceuticals REGN Stock Holding History

Kestra Advisory Services’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.45M Buy
4,470
+65
+1% +$49.8K 0.01% 988
2025
Q4 		$3.4M Buy
4,405
+571
+15% +$388K 0.01% 943
2025
Q3 		$2.16M Buy
3,834
+151
+4% +$85.4K 0.01% 1107
2025
Q2 		$1.93M Sell
3,683
-1,222
-25% -$682K 0.01% 1094
2025
Q1 		$3.11M Sell
4,905
-1,835
-27% -$1.26M 0.02% 783
2024
Q4 		$4.8M Buy
6,740
+52
+0.8% +$43.6K 0.03% 592
2024
Q3 		$7.03M Buy
6,688
+533
+9% +$593K 0.04% 477
2024
Q2 		$6.47M Buy
6,155
+50
+0.8% +$48.5K 0.04% 501
2024
Q1 		$5.88M Buy
6,105
+1,167
+24% +$1.11M 0.04% 472
2023
Q4 		$4.34M Buy
4,938
+664
+16% +$547K 0.04% 505
2023
Q3 		$3.52M Sell
4,274
-17
-0.4% -$13.4K 0.03% 496
2023
Q2 		$3.08M Sell
4,291
-264
-6% -$204K 0.03% 533
2023
Q1 		$3.74M Sell
4,555
-1,777
-28% -$1.34M 0.04% 437
2022
Q4 		$4.57M Buy
6,332
+725
+13% +$535K 0.04% 470
2022
Q3 		$3.86M Sell
5,607
-383
-6% -$241K 0.04% 446
2022
Q2 		$3.54M Sell
5,990
-1,431
-19% -$930K 0.04% 465
2022
Q1 		$5.18M Buy
7,421
+943
+15% +$597K 0.05% 359
2021
Q4 		$4.09M Sell
6,478
-770
-11% -$473K 0.04% 426
2021
Q3 		$4.39M Buy
7,248
+452
+7% +$281K 0.04% 436
2021
Q2 		$3.8M Buy
6,796
+1,850
+37% +$937K 0.04% 435
2021
Q1 		$2.34M Buy
4,946
+1,855
+60% +$903K 0.03% 538
2020
Q4 		$1.48M Buy
3,091
+3,058
+9,267% +$1.65M 0.02% 701
2020
Q3 		$1.45M Buy
+33
New +$20K 0.03% 513

Other funds holding REGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Kestra Advisory Services's REGN Position: Q1 2026 in Review

Kestra Advisory Services increased its Regeneron Pharmaceuticals (REGN) stake by 1.5% in Q1 2026, buying an estimated $49.8K and bringing the position to 4,470 shares worth $3.45M. The position accounts for 0.01% of the portfolio, ranked #988.

Kestra Advisory Services first reported a position in REGN in Q3 2020 and has held it in 23 quarters since. The position peaked at $7.03M in Q3 2024. 1,392 funds tracked by Wall St. Rank hold REGN as of Q1 2026.

  • Kestra Advisory Services held 4,470 shares of Regeneron Pharmaceuticals worth $3.45M as of Q1 2026.
  • Kestra Advisory Services bought 65 Regeneron Pharmaceuticals shares in Q1 2026, an estimated $49.8K.
  • Regeneron Pharmaceuticals made up 0.01% of Kestra Advisory Services's portfolio in Q1 2026, its #988 holding.
  • Kestra Advisory Services first reported a position in Regeneron Pharmaceuticals in Q3 2020 and has held it in 23 quarters since.
  • Kestra Advisory Services's Regeneron Pharmaceuticals position peaked at $7.03M in Q3 2024.
  • 1,392 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2026.

Based on Kestra Advisory Services's 13F filing for Q1 2026, filed 30 Apr 2026.